Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy

Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy

Bladder cancer (BCa) is the tenth most commonly diagnosed malignant cancer worldwide. Although adjuvant chemotherapy following radical cystectomy is a common therapy for muscle invasive bladder cancer patients, no applicable biomarkers exist to predict which patients will benefit from chemotherapy....

Full description

Bibliographic Details
Main Authors: Helge Taubert, Markus Eckstein, Elena Epple, Rudolf Jung, Katrin Weigelt, Verena Lieb, Danijel Sikic, Robert Stöhr, Carol Geppert, Veronika Weyerer, Simone Bertz, Astrid Kehlen, Arndt Hartmann, Bernd Wullich, Sven Wach
Format: Article
Language:English
Published: MDPI AG 2021-01-01
Series:Cells
Subjects:
CCL2
CD68
CD163
bladder cancer
immune cells
chemotherapy
Online Access:https://www.mdpi.com/2073-4409/10/1/159

Internet

https://www.mdpi.com/2073-4409/10/1/159

Similar Items